Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis

BACKGROUND: No meta-analysis has analysed efficacy and safety of fast-acting aspart insulin (FIAsp) with insulin pump in type 1 diabetes mellitus (T1DM). METHODS: Electronic databases were searched for randomised controlled trials (RCTs) involving T1DM patients on insulin pump receiving FIAsp in int...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, Mohindra, Ritin, Mahajan, Kunal, Sharma, Meha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925142/
https://www.ncbi.nlm.nih.gov/pubmed/35746893
http://dx.doi.org/10.4093/dmj.2022.0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925142/
https://www.ncbi.nlm.nih.gov/pubmed/35746893
http://dx.doi.org/10.4093/dmj.2022.0035

Ejemplares similares